Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0081 | 0.9 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.045 | 0.9 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |